Advertisement
UK markets closed
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • CRUDE OIL

    83.78
    +0.97 (+1.17%)
     
  • GOLD FUTURES

    2,344.10
    +5.70 (+0.24%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,696.13
    +660.48 (+1.29%)
     
  • CMC Crypto 200

    1,394.05
    +11.48 (+0.83%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Can Abbott’s Latest Approval Accelerate Its Established Pharmaceuticals Business?

On August 30, ABT announced the regulatory approval for its dydrogesterone oral medication in Russia and the Netherlands for invitro fertilization treatment.